triamcinolone has been researched along with Cancer of the Retina in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kotsolis, A; Ladas, ID; Moschos, MM; Papakostas, TD; Rouvas, AA; Vavvas, D; Vergados, I | 1 |
| Narayanan, R; Sahu, AK | 1 |
| Rutishauser-Arnold, Y; Thölen, AM | 1 |
| Bakri, SJ; Ekdawi, NS | 1 |
1 trial(s) available for triamcinolone and Cancer of the Retina
| Article | Year |
|---|---|
Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Hemangioma; Humans; Injections; Male; Photochemotherapy; Ranibizumab; Retina; Retinal Neoplasms; Time Factors; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body | 2009 |
3 other study(ies) available for triamcinolone and Cancer of the Retina
| Article | Year |
|---|---|
Intravitreal ranibizumab, intravitreal ranibizumab with photodynamic therapy (PDT), and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Hemangioma; Humans; Injections; Photochemotherapy; Ranibizumab; Retina; Retinal Neoplasms; Time Factors; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body | 2010 |
[Periocular sub-tenon triamcinolone acetonide injections for the treatment of retinal angiomatous proliferation (RAP) and occult choroidal neovascularisation].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Choroidal Neovascularization; Female; Hemangioma; Humans; Injections; Male; Retinal Neoplasms; Retinal Neovascularization; Retrospective Studies; Treatment Outcome; Triamcinolone | 2007 |
Intravitreal triamcinolone and bevacizumab combination therapy for refractory choroidal neovascularization with retinal angiomatous proliferation.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Drug Combinations; Female; Hemangioma; Humans; Retinal Neoplasms; Triamcinolone | 2008 |